Copy For Citation
TOYGAR DENİZ M., AKHAN S., SAYAN M., Tamer G. S., AZAK KARALİ E.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.28, no.1, pp.25-31, 2022 (ESCI)
-
Publication Type:
Article / Article
-
Volume:
28
Issue:
1
-
Publication Date:
2022
-
Doi Number:
10.4274/vhd.galenos.2022.2021-3-2
-
Journal Name:
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
-
Journal Indexes:
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
-
Page Numbers:
pp.25-31
-
Keywords:
Hepatitis C virus, correlation, viral load, hepatitis C antibodies, CLINICAL UTILITY, ENZYME-IMMUNOASSAY, ASSAY, QUANTIFICATION, EPIDEMIOLOGY, PERFORMANCE, INFECTION, BURDEN, RNA
-
Kocaeli University Affiliated:
Yes
Abstract
Objectives: Recently, with the use of direct-acting antivirals (DAA) for treating chronic hepatitis C (CHC), the success rate has exceeded 90%. The implementation of these strong therapies has reduced the role of monitoring therapy with hepatitis C virus (HCV)-RNA tests. The current study compares the HCV-core antigen test (HCV-Ag) with HCV-RNA in terms of correlation, effectiveness and cost in patients who started DAA and to evaluate the usability of HCV-Ag as a routine laboratory test.